ArticleFrontiers in endocrinology2026
The impact of regressed endometrial hyperplasia on reproductive outcomes following frozen embryo transfer: a propensity score-matched cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the impact of regressed endometrial hyperplasia (EH) on assisted reproductive technology outcomes, particularly in comparison with infertile women with a relatively normal endometrium. Methods: This retrospective study included 95 patients with EH regression after conservative treatment and 30634 infertile controls at the Reproductive Medicine Center from January 2015 to December 2022. Propensity score matching was performed at a ratio of 1:4 between EH and control patients following first frozen embryo transfer. Pregnancy, obstetric and neonatal outcomes were compared between matched pairs. Subgroup analysis was performed between EH patients with and without atypia. Binary logistic regression was conducted to identify risk factors for live birth among EH patients. The primary outcome was live birth rate. Results: Compared with matched controls, patients with EH exhibited a significantly lower live birth rate (31.6% vs. 49.2%, Conclusions: Even after complete remission, EH remained associated with a reduced likelihood of live birth following FET. Prolonged progesterone therapy and delayed remission further diminished the live birth likelihood, highlighting the need for optimized treatment and individualized conception counseling in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.